We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cancer Patients Could Benefit From “Off-label” Drugs

News   Sep 30, 2019 | By Laura Elizabeth Lansdowne, Science Writer, Technology Networks

 
Cancer Patients Could Benefit From “Off-label” Drugs

Laura Elizabeth Lansdowne

Senior Science Writer

 
 
 

RELATED ARTICLES

Brain Chip Makes for Precision Cancer Treatment

News

Researchers have developed a microfluidic brain chip which could be used for simultaneously assessing drug treatments for malignant brain tumors.

READ MORE

Targeting “DNA Rewiring” To Reduce Breast Cancer Relapse

News

Epigenetic changes occur in the DNA of breast cancer cells that have developed a resistance to hormone therapy, an effective treatment for ER+ breast cancer, which accounts for 70% of all diagnoses.

READ MORE

Ten Years of Unraveling the Genomics of Parkinson’s Disease

News

In an article published in the Journal of Parkinson's Disease, the International Parkinson Disease Genomics Consortium (IPDGC) consortium reviews the progress made over the past decade in the genomics of Parkinson's disease (PD).

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE